{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T22:45:33Z","timestamp":1795214733596,"version":"4.10.3"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T00:00:00Z","timestamp":1583107200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T00:00:00Z","timestamp":1583107200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["RF1 AG058942"],"award-info":[{"award-number":["RF1 AG058942"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["R01 AG057452"],"award-info":[{"award-number":["R01 AG057452"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["R03 AG054936"],"award-info":[{"award-number":["R03 AG054936"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["R01 LM012535"],"award-info":[{"award-number":["R01 LM012535"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["RF1 AG061872"],"award-info":[{"award-number":["RF1 AG061872"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["P30AG10161"],"award-info":[{"award-number":["P30AG10161"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG15819"],"award-info":[{"award-number":["R01AG15819"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["U01AG46152"],"award-info":[{"award-number":["U01AG46152"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["U01AG61356"],"award-info":[{"award-number":["U01AG61356"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["R01 AG046171"],"award-info":[{"award-number":["R01 AG046171"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["RF1 AG051550"],"award-info":[{"award-number":["RF1 AG051550"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["3U01 AG024904-09S4"],"award-info":[{"award-number":["3U01 AG024904-09S4"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["RF1 AG058942"],"award-info":[{"award-number":["RF1 AG058942"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["RF1 AG058942"],"award-info":[{"award-number":["RF1 AG058942"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["R01 AG057452"],"award-info":[{"award-number":["R01 AG057452"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging"},{"DOI":"10.13039\/100008982","name":"Qatar National Research Fund","doi-asserted-by":"publisher","award":["NPRP8-061-3-011"],"award-info":[{"award-number":["NPRP8-061-3-011"]}],"id":[{"id":"10.13039\/100008982","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008982","name":"Qatar National Research Fund","doi-asserted-by":"publisher","award":["NPRP8-061-3-011"],"award-info":[{"award-number":["NPRP8-061-3-011"]}],"id":[{"id":"10.13039\/100008982","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Late-onset Alzheimer\u2019s disease (AD) can, in part, be considered a metabolic disease. Besides age, female sex and\n                    <jats:italic>APOE<\/jats:italic>\n                    \u03b54 genotype represent strong risk factors for AD that also give rise to large metabolic differences. We systematically investigated group-specific metabolic alterations by conducting stratified association analyses of 139 serum metabolites in 1,517 individuals from the AD Neuroimaging Initiative with AD biomarkers. We observed substantial sex differences in effects of 15 metabolites with partially overlapping differences for\n                    <jats:italic>APOE<\/jats:italic>\n                    \u03b54 status groups. Several group-specific metabolic alterations were not observed in unstratified analyses using sex and\n                    <jats:italic>APOE<\/jats:italic>\n                    \u03b54 as covariates. Combined stratification revealed further subgroup-specific metabolic effects limited to\n                    <jats:italic>APOE<\/jats:italic>\n                    \u03b54+ females. The observed metabolic alterations suggest that females experience greater impairment of mitochondrial energy production than males. Dissecting metabolic heterogeneity in AD pathogenesis can therefore enable grading the biomedical relevance for specific pathways within specific subgroups, guiding the way to personalized medicine.\n                  <\/jats:p>","DOI":"10.1038\/s41467-020-14959-w","type":"journal-article","created":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T06:03:15Z","timestamp":1583128995000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":206,"title":["Sex and APOE \u03b54 genotype modify the Alzheimer\u2019s disease serum metabolome"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4666-0923","authenticated-orcid":false,"given":"Matthias","family":"Arnold","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwangsik","family":"Nho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Kueider-Paisley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler","family":"Massaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Huynh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Brauner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siamak","family":"MahmoudianDehkordi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3267-7070","authenticated-orcid":false,"given":"Gregory","family":"Louie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Arthur","family":"Moseley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Will","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa St","family":"John-Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3532-565X","authenticated-orcid":false,"given":"Jessica D.","family":"Tenenbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colette","family":"Blach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta D.","family":"Brinton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3966-6320","authenticated-orcid":false,"given":"Rebecca","family":"Baillie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8615-2413","authenticated-orcid":false,"given":"Xianlin","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9239-8794","authenticated-orcid":false,"given":"John Q.","family":"Trojanowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie M.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"Weiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenia","family":"Trushina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon B.","family":"Toledo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2593-4665","authenticated-orcid":false,"given":"Peter J.","family":"Meikle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Krumsiek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Murali","family":"Doraiswamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1376-8532","authenticated-orcid":false,"given":"Andrew J.","family":"Saykin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1858-5732","authenticated-orcid":false,"given":"Rima","family":"Kaddurah-Daouk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2368-7322","authenticated-orcid":false,"given":"Gabi","family":"Kastenm\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,2]]},"reference":[{"key":"14959_CR1","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.jalz.2017.02.001","volume":"13","author":"As Association","year":"2017","unstructured":"Association, As 2017 Alzheimer\u2019s disease facts and figures. Alzheimer\u2019s Dement. 13, 325\u2013373 (2017).","journal-title":"Alzheimer\u2019s Dement."},{"key":"14959_CR2","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1212\/WNL.0b013e31828726f5","volume":"80","author":"LE Hebert","year":"2013","unstructured":"Hebert, L. E., Weuve, J., Scherr, P. A. & Evans, D. A. Alzheimer disease in the United States (2010-2050) estimated using the 2010 census. Neurology 80, 1778\u20131783 (2013).","journal-title":"Neurology"},{"key":"14959_CR3","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2147\/CLEP.S37929","volume":"6","author":"MM Mielke","year":"2014","unstructured":"Mielke, M. M., Vemuri, P. & Rocca, W. A. Clinical epidemiology of Alzheimer\u2019s disease: assessing sex and gender differences. Clin. Epidemiol. 6, 37\u201348 (2014).","journal-title":"Clin. Epidemiol."},{"key":"14959_CR4","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13195-016-0188-8","volume":"8","author":"M Prince","year":"2016","unstructured":"Prince, M. et al. Recent global trends in the prevalence and incidence of dementia, and survival with dementia. Alzheimer\u2019s Res. Ther. 8, 23 (2016).","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"14959_CR5","doi-asserted-by":"publisher","first-page":"S51","DOI":"10.1017\/cjn.2016.36","volume":"43","author":"KM Fiest","year":"2016","unstructured":"Fiest, K. M. et al. The prevalence and incidence of dementia due to Alzheimer\u2019s disease: a systematic review and meta-analysis. Can. J. Neurol. Sci. 43, S51\u2013S82 (2016).","journal-title":"Can. J. Neurol. Sci."},{"key":"14959_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11398","volume":"7","author":"FE Matthews","year":"2016","unstructured":"Matthews, F. E. et al. A two decade dementia incidence comparison from the cognitive function and ageing studies I and II. Nat. Commun. 7, 11398 (2016).","journal-title":"Nat. Commun."},{"key":"14959_CR7","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/j.jalz.2018.04.008","volume":"14","author":"RA Nebel","year":"2018","unstructured":"Nebel, R. A. et al. Understanding the impact of sex and gender in Alzheimer\u2019s disease: a call to action. Alzheimer\u2019s Dement. 14, 1171\u20131183 (2018).","journal-title":"Alzheimer\u2019s Dement."},{"key":"14959_CR8","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1212\/WNL.57.1.89","volume":"57","author":"EL Mortensen","year":"2001","unstructured":"Mortensen, E. L. & Hogh, P. A gender difference in the association between APOE genotype and age-related cognitive decline. Neurology 57, 89\u201395 (2001).","journal-title":"Neurology"},{"key":"14959_CR9","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1002\/ana.24135","volume":"75","author":"A Altmann","year":"2014","unstructured":"Altmann, A., Tian, L., Henderson, V. W. & Greicius, M. D. Alzheimer\u2019sDisease Neuroimaging Initiative Investigators. Sex modifies the APOE-related risk of developing Alzheimer disease. Ann. Neurol. 75, 563\u2013573 (2014).","journal-title":"Ann. Neurol."},{"key":"14959_CR10","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.neurobiolaging.2010.05.017","volume":"33","author":"MA Beydoun","year":"2012","unstructured":"Beydoun, M. A. et al. Sex differences in the association of the apolipoprotein E epsilon 4 allele with incidence of dementia, cognitive impairment, and decline. Neurobiol. Aging 33, 720\u2013731 e724 (2012).","journal-title":"Neurobiol. Aging"},{"key":"14959_CR11","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1196\/annals.1297.005","volume":"1019","author":"EH Corder","year":"2004","unstructured":"Corder, E. H. et al. The biphasic relationship between regional brain senile plaque and neurofibrillary tangle distributions: modification by age, sex, and APOE polymorphism. Ann. N. Y. Acad. Sci. 1019, 24\u201328 (2004).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"14959_CR12","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.neuron.2012.11.020","volume":"76","author":"RW Mahley","year":"2012","unstructured":"Mahley, R. W. & Huang, Y. Apolipoprotein e sets the stage: response to injury triggers neuropathology. Neuron 76, 871\u2013885 (2012).","journal-title":"Neuron"},{"key":"14959_CR13","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1001\/jamaneurol.2017.2188","volume":"74","author":"SC Neu","year":"2017","unstructured":"Neu, S. C. et al. Apolipoprotein E genotype and sex risk factors for alzheimer disease: a meta-analysis. JAMA Neurol. 74, 1178\u20131189 (2017).","journal-title":"JAMA Neurol."},{"key":"14959_CR14","doi-asserted-by":"publisher","first-page":"8254","DOI":"10.1523\/JNEUROSCI.0305-12.2012","volume":"32","author":"JS Damoiseaux","year":"2012","unstructured":"Damoiseaux, J. S. et al. Gender modulates the APOE epsilon4 effect in healthy older adults: convergent evidence from functional brain connectivity and spinal fluid tau levels. J. Neurosci. 32, 8254\u20138262 (2012).","journal-title":"J. Neurosci."},{"key":"14959_CR15","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.neuroimage.2014.04.081","volume":"98","author":"V Heise","year":"2014","unstructured":"Heise, V. et al. Apolipoprotein E genotype, gender and age modulate connectivity of the hippocampus in healthy adults. Neuroimage 98, 23\u201330 (2014).","journal-title":"Neuroimage"},{"key":"14959_CR16","doi-asserted-by":"publisher","first-page":"26663","DOI":"10.18632\/oncotarget.5185","volume":"6","author":"F Sampedro","year":"2015","unstructured":"Sampedro, F. et al. APOE-by-sex interactions on brain structure and metabolism in healthy elderly controls. Oncotarget 6, 26663\u201326674 (2015).","journal-title":"Oncotarget"},{"key":"14959_CR17","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41582-018-0032-9","volume":"14","author":"MT Ferretti","year":"2018","unstructured":"Ferretti, M. T. et al. Sex differences in Alzheimer disease\u2014the gateway to precision medicine. Nat. Rev. Neurol. 14, 457\u2013469 (2018).","journal-title":"Nat. Rev. Neurol."},{"key":"14959_CR18","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1001\/jamaneurol.2014.4821","volume":"72","author":"CR Jack Jr.","year":"2015","unstructured":"Jack, C. R. Jr. et al. Age, sex, and APOE epsilon4 effects on memory, brain structure, and beta-amyloid across the adult life span. JAMA Neurol. 72, 511\u2013519 (2015).","journal-title":"JAMA Neurol."},{"key":"14959_CR19","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.dadm.2018.06.004","volume":"10","author":"EE Sundermann","year":"2018","unstructured":"Sundermann, E. E., Tran, M., Maki, P. M. & Bondi, M. W. Sex differences in the association between apolipoprotein E epsilon4 allele and Alzheimer\u2019s disease markers. Alzheimer\u2019s Dement. (Amst.) 10, 438\u2013447 (2018).","journal-title":"Alzheimer\u2019s Dement. (Amst.)"},{"key":"14959_CR20","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1212\/01.wnl.0000288180.21984.cb","volume":"70","author":"B Caracciolo","year":"2008","unstructured":"Caracciolo, B. et al. Occurrence of cognitive impairment and dementia in the community: a 9-year-long prospective study. Neurology 70, 1778\u20131785 (2008).","journal-title":"Neurology"},{"key":"14959_CR21","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1212\/WNL.0b013e3182452862","volume":"78","author":"RO Roberts","year":"2012","unstructured":"Roberts, R. O. et al. The incidence of MCI differs by subtype and is higher in men: the Mayo Clinic Study of Aging. Neurology 78, 342\u2013351 (2012).","journal-title":"Neurology"},{"key":"14959_CR22","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/ana.410400111","volume":"40","author":"BT Hyman","year":"1996","unstructured":"Hyman, B. T. et al. Apolipoprotein E and cognitive change in an elderly population. Ann. Neurol. 40, 55\u201366 (1996).","journal-title":"Ann. Neurol."},{"key":"14959_CR23","doi-asserted-by":"crossref","unstructured":"Buckley, R. F. et al. Sex, amyloid, and APOE epsilon4 and risk of cognitive decline in preclinical Alzheimer\u2019s disease: Findings from three well-characterized cohorts. Alzheimer\u2019s Dement. 14, 1193-1203 (2018).","DOI":"10.1016\/j.jalz.2018.04.010"},{"key":"14959_CR24","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1007\/s11306-015-0829-0","volume":"11","author":"J Krumsiek","year":"2015","unstructured":"Krumsiek, J. et al. Gender-specific pathway differences in the human serum metabolome. Metabolomics 11, 1815\u20131833 (2015).","journal-title":"Metabolomics"},{"key":"14959_CR25","doi-asserted-by":"publisher","first-page":"e1002215","DOI":"10.1371\/journal.pgen.1002215","volume":"7","author":"K Mittelstrass","year":"2011","unstructured":"Mittelstrass, K. et al. Discovery of sexual dimorphisms in metabolic and genetic biomarkers. PLoS Genet. 7, e1002215 (2011).","journal-title":"PLoS Genet."},{"key":"14959_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/srep43701","volume":"7","author":"LA Johnson","year":"2017","unstructured":"Johnson, L. A., Torres, E. R., Impey, S., Stevens, J. F. & Raber, J. Apolipoprotein E4 and insulin resistance interact to impair cognition and alter the epigenome and metabolome. Sci. Rep. 7, 43701 (2017).","journal-title":"Sci. Rep."},{"key":"14959_CR27","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.ab.2006.02.033","volume":"352","author":"S Kochhar","year":"2006","unstructured":"Kochhar, S. et al. Probing gender-specific metabolism differences in humans by nuclear magnetic resonance-based metabonomics. Anal. Biochem. 352, 274\u2013281 (2006).","journal-title":"Anal. Biochem."},{"key":"14959_CR28","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s11306-014-0707-1","volume":"11","author":"WB Dunn","year":"2015","unstructured":"Dunn, W. B. et al. Molecular phenotyping of a UK population: defining the human serum metabolome. Metabolomics 11, 9\u201326 (2015).","journal-title":"Metabolomics"},{"key":"14959_CR29","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1111\/acel.12064","volume":"12","author":"V Gonzalez-Covarrubias","year":"2013","unstructured":"Gonzalez-Covarrubias, V. et al. Lipidomics of familial longevity. Aging Cell 12, 426\u2013434 (2013).","journal-title":"Aging Cell"},{"key":"14959_CR30","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1093\/ije\/dyt094","volume":"42","author":"C Menni","year":"2013","unstructured":"Menni, C. et al. Metabolomic markers reveal novel pathways of ageing and early development in human populations. Int. J. Epidemiol. 42, 1111\u20131119 (2013).","journal-title":"Int. J. Epidemiol."},{"key":"14959_CR31","doi-asserted-by":"publisher","first-page":"5","DOI":"10.2174\/156720512799015064","volume":"9","author":"H Cai","year":"2012","unstructured":"Cai, H. et al. Metabolic dysfunction in Alzheimer\u2019s disease and related neurodegenerative disorders. Curr. Alzheimer\u2019s Res. 9, 5\u201317 (2012).","journal-title":"Curr. Alzheimer\u2019s Res."},{"key":"14959_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-14420-x","volume":"7","author":"KC Sonntag","year":"2017","unstructured":"Sonntag, K. C. et al. Late-onset Alzheimer\u2019s disease is associated with inherent changes in bioenergetics profiles. Sci. Rep. 7, 14038 (2017).","journal-title":"Sci. Rep."},{"key":"14959_CR33","first-page":"1376","volume":"65","author":"C Procaccini","year":"2016","unstructured":"Procaccini, C. et al. Role of metabolism in neurodegenerative disorders. Metabolomics 65, 1376\u20131390 (2016).","journal-title":"Metabolomics"},{"key":"14959_CR34","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1111\/j.1474-9726.2012.00865.x","volume":"11","author":"Z Yu","year":"2012","unstructured":"Yu, Z. et al. Human serum metabolic profiles are age dependent. Aging Cell 11, 960\u2013967 (2012).","journal-title":"Aging Cell"},{"key":"14959_CR35","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1681\/ASN.2014111099","volume":"27","author":"P Sekula","year":"2016","unstructured":"Sekula, P. et al. A metabolome-wide association study of kidney function and disease in the general population. J. Am. Soc. Nephrol. 27, 1175\u20131188 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"14959_CR36","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.csbj.2017.05.003","volume":"15","author":"IF Tudorache","year":"2017","unstructured":"Tudorache, I. F., Trusca, V. G. & Gafencu, A. V. Apolipoprotein E\u2014a multifunctional protein with implications in various pathologies as a result of its structural features. Comput. Struct. Biotechnol. J. 15, 359\u2013365 (2017).","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"14959_CR37","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1038\/nature09270","volume":"466","author":"TM Teslovich","year":"2010","unstructured":"Teslovich, T. M. et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 466, 707\u2013713 (2010).","journal-title":"Nature"},{"key":"14959_CR38","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/ng.2982","volume":"46","author":"SY Shin","year":"2014","unstructured":"Shin, S. Y. et al. An atlas of genetic influences on human blood metabolites. Nat. Genet. 46, 543\u20135502 (2014).","journal-title":"Nat. Genet."},{"key":"14959_CR39","doi-asserted-by":"publisher","first-page":"819","DOI":"10.3233\/JAD-160925","volume":"60","author":"MM Mielke","year":"2017","unstructured":"Mielke, M. M. et al. The association between plasma ceramides and sphingomyelins and risk of alzheimer\u2019s disease differs by sex and APOE in the baltimore longitudinal study of aging. J. Alzheimer\u2019s Dis. 60, 819\u2013828 (2017).","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"14959_CR40","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/ng.3809","volume":"49","author":"T Long","year":"2017","unstructured":"Long, T. et al. Whole-genome sequencing identifies common-to-rare variants associated with human blood metabolites. Nat. Genet. 49, 568\u2013578 (2017).","journal-title":"Nat. Genet."},{"key":"14959_CR41","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1212\/WNL.0b013e318264e380","volume":"79","author":"MM Mielke","year":"2012","unstructured":"Mielke, M. M. et al. Serum ceramides increase the risk of Alzheimer disease: the Women\u2019s Health and Aging Study II. Neurology 79, 633\u2013641 (2012).","journal-title":"Neurology"},{"key":"14959_CR42","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.jalz.2018.01.003","volume":"14","author":"J Tynkkynen","year":"2018","unstructured":"Tynkkynen, J. et al. Association of branched-chain amino acids and other circulating metabolites with risk of incident dementia and Alzheimer\u2019s disease: a prospective study in eight cohorts. Alzheimer\u2019s Dement. 14, 723\u2013733 (2018).","journal-title":"Alzheimer\u2019s Dement."},{"key":"14959_CR43","doi-asserted-by":"publisher","first-page":"e63644","DOI":"10.1371\/journal.pone.0063644","volume":"8","author":"E Trushina","year":"2013","unstructured":"Trushina, E., Dutta, T., Persson, X. M., Mielke, M. M. & Petersen, R. C. Identification of altered metabolic pathways in plasma and CSF in mild cognitive impairment and Alzheimer\u2019s disease using metabolomics. PLoS ONE 8, e63644 (2013).","journal-title":"PLoS ONE"},{"key":"14959_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2011.55","volume":"1","author":"M Oresic","year":"2011","unstructured":"Oresic, M. et al. Metabolome in progression to Alzheimer\u2019s disease. Transl. Psychiatry 1, e57 (2011).","journal-title":"Transl. Psychiatry"},{"key":"14959_CR45","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1016\/j.jalz.2017.01.020","volume":"13","author":"JB Toledo","year":"2017","unstructured":"Toledo, J. B. et al. Metabolic network failures in Alzheimer\u2019s disease: a biochemical road map. Alzheimer\u2019s Dement. 13, 965\u2013984 (2017).","journal-title":"Alzheimer\u2019s Dement."},{"key":"14959_CR46","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jprot.2014.01.014","volume":"104","author":"R Gonzalez-Dominguez","year":"2014","unstructured":"Gonzalez-Dominguez, R., Garcia-Barrera, T. & Gomez-Ariza, J. L. Combination of metabolomic and phospholipid-profiling approaches for the study of Alzheimer\u2019s disease. J. Proteom. 104, 37\u201347 (2014).","journal-title":"J. Proteom."},{"key":"14959_CR47","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.neurobiolaging.2013.08.001","volume":"35","author":"L Whiley","year":"2014","unstructured":"Whiley, L. et al. Evidence of altered phosphatidylcholine metabolism in Alzheimer\u2019s disease. Neurobiol. Aging 35, 271\u2013278 (2014).","journal-title":"Neurobiol. Aging"},{"key":"14959_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2014.127","volume":"5","author":"P Proitsi","year":"2015","unstructured":"Proitsi, P. et al. Plasma lipidomics analysis finds long chain cholesteryl esters to be associated with Alzheimer\u2019s disease. Transl. Psychiatry 5, e494 (2015).","journal-title":"Transl. Psychiatry"},{"key":"14959_CR49","doi-asserted-by":"publisher","first-page":"e0119452","DOI":"10.1371\/journal.pone.0119452","volume":"10","author":"SF Graham","year":"2015","unstructured":"Graham, S. F. et al. Untargeted metabolomic analysis of human plasma indicates differentially affected polyamine and L-arginine metabolism in mild cognitive impairment subjects converting to Alzheimer\u2019s disease. PLoS ONE 10, e0119452 (2015).","journal-title":"PLoS ONE"},{"key":"14959_CR50","doi-asserted-by":"publisher","first-page":"e1002482","DOI":"10.1371\/journal.pmed.1002482","volume":"15","author":"VR Varma","year":"2018","unstructured":"Varma, V. R. et al. Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: a targeted metabolomics study. PLoS Med. 15, e1002482 (2018).","journal-title":"PLoS Med."},{"issue":"2","key":"14959_CR51","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3390\/metabo7020028","volume":"7","author":"Xiaobei Pan","year":"2017","unstructured":"Pan, X. et al. Metabolomic profiling of bile acids in clinical and experimental samples of Alzheimer\u2019s disease. Metabolites 7, https:\/\/doi.org\/10.3390\/metabo7020028 (2017).","journal-title":"Metabolites"},{"key":"14959_CR52","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jalz.2018.07.217","volume":"15","author":"S MahmoudianDehkordi","year":"2019","unstructured":"MahmoudianDehkordi, S. et al. Altered bile acid profile associates with cognitive impairment in Alzheimer\u2019s disease\u2013an emerging role for gut microbiome. Alzheimer\u2019s Dement. 15, 76\u201392 (2019).","journal-title":"Alzheimer\u2019s Dement."},{"key":"14959_CR53","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.jalz.2018.08.012","volume":"15","author":"K Nho","year":"2019","unstructured":"Nho, K. et al. Altered bile acid profile in mild cognitive impairment and Alzheimer\u2019s disease: relationship to neuroimaging and CSF biomarkers. Alzheimer\u2019s Dement. 15, 232\u2013244 (2019).","journal-title":"Alzheimer\u2019s Dement."},{"key":"14959_CR54","unstructured":"Jack, C. R., Jr. et al. in Alzheimer\u2019s Association International Conference. 1\u201357 (Alzheimer\u2019s Association)."},{"key":"14959_CR55","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1212\/WNL.0000000000002923","volume":"87","author":"CR Jack Jr.","year":"2016","unstructured":"Jack, C. R. Jr. et al. A\/T\/N: an unbiased descriptive classification scheme for Alzheimer disease biomarkers. Neurology 87, 539\u2013547 (2016).","journal-title":"Neurology"},{"key":"14959_CR56","doi-asserted-by":"publisher","first-page":"S161","DOI":"10.3233\/JAD-179939","volume":"64","author":"DA Bennett","year":"2018","unstructured":"Bennett, D. A. et al. Religious orders study and rush memory and aging project. J. Alzheimer\u2019s Dis. 64, S161\u2013S189 (2018).","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"14959_CR57","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.1016\/j.ddmec.2009.02.001","volume":"6","author":"S Sharma","year":"2009","unstructured":"Sharma, S. & Black, S. M. Carnitine homeostasis, mitochondrial function, and cardiovascular disease. Drug Discov. Today Dis. Mech. 6, e31\u2013e39 (2009).","journal-title":"Drug Discov. Today Dis. Mech."},{"key":"14959_CR58","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/nrendo.2014.171","volume":"10","author":"CJ Lynch","year":"2014","unstructured":"Lynch, C. J. & Adams, S. H. Branched-chain amino acids in metabolic signalling and insulin resistance. Nat. Rev. Endocrinol. 10, 723\u2013736 (2014).","journal-title":"Nat. Rev. Endocrinol."},{"key":"14959_CR59","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s00726-017-2508-0","volume":"50","author":"M Adeva-Andany","year":"2018","unstructured":"Adeva-Andany, M. et al. Insulin resistance and glycine metabolism in humans. Amino Acids 50, 11\u201327 (2018).","journal-title":"Amino Acids"},{"key":"14959_CR60","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1146\/annurev.nutr.012809.104638","volume":"30","author":"JM Phang","year":"2010","unstructured":"Phang, J. M., Liu, W. & Zabirnyk, O. Proline metabolism and microenvironmental stress. Annu Rev. Nutr. 30, 441\u2013463 (2010).","journal-title":"Annu Rev. Nutr."},{"key":"14959_CR61","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1007\/s00125-013-2839-7","volume":"56","author":"RN Feng","year":"2013","unstructured":"Feng, R. N. et al. Histidine supplementation improves insulin resistance through suppressed inflammation in obese women with the metabolic syndrome: a randomised controlled trial. Diabetologia 56, 985\u2013994 (2013).","journal-title":"Diabetologia"},{"key":"14959_CR62","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1093\/ajcn\/87.6.1860","volume":"87","author":"M Watanabe","year":"2008","unstructured":"Watanabe, M. et al. Consequences of low plasma histidine in chronic kidney disease patients: associations with inflammation, oxidative stress, and mortality. Am. J. Clin. Nutr. 87, 1860\u20131866 (2008).","journal-title":"Am. J. Clin. Nutr."},{"key":"14959_CR63","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.15252\/embj.201695518","volume":"36","author":"H Huang","year":"2017","unstructured":"Huang, H. et al. Role of glutamine and interlinked asparagine metabolism in vessel formation. EMBO J. 36, 2334\u20132352 (2017).","journal-title":"EMBO J."},{"key":"14959_CR64","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/2049-1891-4-27","volume":"4","author":"MR Ruth","year":"2013","unstructured":"Ruth, M. R. & Field, C. J. The immune modifying effects of amino acids on gut-associated lymphoid tissue. J. Anim. Sci. Biotechnol. 4, 27 (2013).","journal-title":"J. Anim. Sci. Biotechnol."},{"key":"14959_CR65","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.cmet.2009.02.002","volume":"9","author":"CB Newgard","year":"2009","unstructured":"Newgard, C. B. et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab. 9, 311\u2013326 (2009).","journal-title":"Cell Metab."},{"key":"14959_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-27958-1","volume":"8","author":"ME Lacruz","year":"2018","unstructured":"Lacruz, M. E. et al. Instability of personal human metabotype is linked to all-cause mortality. Sci. Rep. 8, 9810 (2018).","journal-title":"Sci. Rep."},{"key":"14959_CR67","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nm.3466","volume":"20","author":"M Mapstone","year":"2014","unstructured":"Mapstone, M. et al. Plasma phospholipids identify antecedent memory impairment in older adults. Nat. Med. 20, 415\u2013418 (2014).","journal-title":"Nat. Med."},{"key":"14959_CR68","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.jalz.2015.12.008","volume":"12","author":"R Casanova","year":"2016","unstructured":"Casanova, R. et al. Blood metabolite markers of preclinical Alzheimer\u2019s disease in two longitudinally followed cohorts of older individuals. Alzheimer\u2019s Dement. 12, 815\u2013822 (2016).","journal-title":"Alzheimer\u2019s Dement."},{"key":"14959_CR69","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1001\/archneurol.2008.596","volume":"66","author":"T Tapiola","year":"2009","unstructured":"Tapiola, T. et al. Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain. Arch. Neurol. 66, 382\u2013389 (2009).","journal-title":"Arch. Neurol."},{"key":"14959_CR70","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.jalz.2015.04.005","volume":"11","author":"MW Weiner","year":"2015","unstructured":"Weiner, M. W. et al. Impact of the Alzheimer\u2019s disease neuroimaging initiative, 2004 to 2014. Alzheimer\u2019s Dement. 11, 865\u2013884 (2015).","journal-title":"Alzheimer\u2019s Dement."},{"key":"14959_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/sdata.2017.140","volume":"4","author":"L St John-Williams","year":"2017","unstructured":"St John-Williams, L. et al. Targeted metabolomics and medication classification data from participants in the ADNI1 cohort. Sci. Data 4, 170140 (2017).","journal-title":"Sci. Data"},{"key":"14959_CR72","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1016\/j.jalz.2018.01.010","volume":"14","author":"O Hansson","year":"2018","unstructured":"Hansson, O. et al. CSF biomarkers of Alzheimer\u2019s disease concord with amyloid-beta PET and predict clinical progression: a study of fully automated immunoassays in BioFINDER and ADNI cohorts. Alzheimer\u2019s Dement. 14, 1470\u20131481 (2018).","journal-title":"Alzheimer\u2019s Dement."},{"key":"14959_CR73","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.jalz.2015.09.009","volume":"12","author":"T Bittner","year":"2016","unstructured":"Bittner, T. et al. Technical performance of a novel, fully automated electrochemiluminescence immunoassay for the quantitation of beta-amyloid (1\u201342) in human cerebrospinal fluid. Alzheimer\u2019s Dement. 12, 517\u2013526 (2016).","journal-title":"Alzheimer\u2019s Dement."},{"key":"14959_CR74","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.neurobiolaging.2009.07.002","volume":"32","author":"SM Landau","year":"2011","unstructured":"Landau, S. M. et al. Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI. Neurobiol. Aging 32, 1207\u20131218 (2011).","journal-title":"Neurobiol. Aging"},{"key":"14959_CR75","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.jalz.2010.03.003","volume":"6","author":"WJ Jagust","year":"2010","unstructured":"Jagust, W. J. et al. The Alzheimer\u2019s Disease neuroimaging initiative positron emission tomography core. Alzheimer\u2019s Dement. 6, 221\u2013229 (2010).","journal-title":"Alzheimer\u2019s Dement."},{"key":"14959_CR76","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/sj.hdy.6800717","volume":"95","author":"J Li","year":"2005","unstructured":"Li, J. & Ji, L. Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix. Heredity (Edinb.) 95, 221\u2013227 (2005).","journal-title":"Heredity (Edinb.)"},{"key":"14959_CR77","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1111\/j.1745-9125.1998.tb01268.x","volume":"36","author":"R Paternoster","year":"1998","unstructured":"Paternoster, R., Brame, R., Mazerolle, P. & Piquero, A. Using the correct statistical test for the equality of regression coefficients. Criminology 36, 859\u2013866 (1998).","journal-title":"Criminology"},{"key":"14959_CR78","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins, J. P. & Thompson, S. G. Quantifying heterogeneity in a meta-analysis. Stat. Med. 21, 1539\u20131558 (2002).","journal-title":"Stat. Med."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-14959-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-14959-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-14959-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T13:55:43Z","timestamp":1670248543000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-14959-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,2]]},"references-count":78,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["14959"],"URL":"https:\/\/doi.org\/10.1038\/s41467-020-14959-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/585455","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,2]]},"assertion":[{"value":"22 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"P.M.D. has received research grants (through Duke University) from Avid\/Lilly, Neuronetrix, Avanir, Salix, Alzheimer\u2019s Drug Discovery Foundation, DOD and NIH. P.M.D. has received speaking or advisory fees from Anthrotronix, Neuroptix, Genomind, Clearview, Verily, RBC, Brain Canada, and CEOs Against Alzheimer\u2019s. P.M.D. owns shares in Muses Labs, Anthrotronix, Evidation Health, Turtle Shell Technologies, and Advera Health whose products are not discussed here. P.M.D. served on the board of Baycrest and serves on the board of Apollo Hospitals. P.M.D. is a co-inventor (through Duke) on patents relating to dementia biomarkers, metabolomics, and therapies, which are unlicensed. R.K.D. is inventor on key patents in the field of metabolomics, including applications for Alzheimer disease. M.A., J.B.T., G.K., M.A.M., J.W.T., R.B., X.H., L.S.J.W., A.J.S., K.N. are co-inventors on patent WO2018049268 in this field. J.B.T. further reports investigator-initiated research support from Eli Lilly unrelated to the work reported here. J.Q.T. may accrue revenue in the future on patents submitted by the University of Pennsylvania wherein he is a co-inventor and he received revenue from the sale of Avid to Eli Lilly as a co-inventor on imaging-related patents submitted by the University of Pennsylvania. L.M.S. is a consultant for Eli Lilly, Novartis, and Roche; he provides QC oversight for the Roche Elecsys immunoassay as part of responsibilities for the ADNI3 study. A.J.S. reports investigator-initiated research support from Eli Lilly unrelated to the work reported here. He has received consulting fees and travel expenses from Eli Lilly and Siemens Healthcare and is a consultant to Arkley BioTek. He also receives support from Springer publishing as an editor-in-chief of Brain Imaging and Behavior. M.W.W. reports stock\/stock options from Elan, Synarc, travel expenses from Novartis, Tohoku University, Fundacio Ace, Travel eDreams, MCI Group, NSAS, Danone Trading, ANT Congress, NeuroVigil, CHRU-Hopital Roger Salengro, Siemens, AstraZeneca, Geneva University Hospitals, Lilly, University of California, San Diego\u2013ADNI, Paris University, Institut Catala de Neurociencies Aplicades, University of New Mexico School of Medicine, Ipsen, Clinical Trials on Alzheimer\u2019s Disease, Pfizer, AD PD meeting. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1148"}}